Loading clinical trials...
Loading clinical trials...
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease (NAFLD Cohort Study)
Conditions
Locations
1
Switzerland
Fondazione Epatocentro Ticino
Lugano, Canton Ticino, Switzerland
Start Date
July 19, 2023
Primary Completion Date
December 1, 2030
Completion Date
December 1, 2030
Last Updated
July 9, 2025
NCT07265544
NCT06632444
NCT06215716
NCT06318169
NCT07321925
NCT06599918
Lead Sponsor
Fondazione Epatocentro Ticino
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions